CTSD and breast carcinoma: SPRED2 appears to activate autophagy by interacting with selective autophagic components, such as LC3 [5], p62, a neighbor of breast cancer susceptibility gene I (BRCA1) and cathepsin D [33], as evidenced by co-immunoprecipitation of these molecules with SPRED2.